Phacilitate Leaders World

Conference speakers

Loading
Joshua M. Hare

Dr Joshua M. Hare

Director, Interdisciplinary Stem Cell Institute (ISCI), Louis Lemberg Professor of Medicine / Co-Founder and Chief Science Office, University of Miami Miller School of Medicine / Longeveron, LLC

Dr. Joshua Hare is Chief Sciences Officer, Senior Associate Dean for Experimental and Cellular Therapeutics, Director of the Interdisciplinary Stem Cell Institute (ISCI), and Louis Lemberg Professor of Medicine at the University of Miami Miller School of Medicine.  Dr. Hare is a practicing cardiologist and an expert in cardiovascular medicine, specializing in heart failure, myocardial infarction, inflammatory diseases of the heart, and heart transplantation.  He is an internationally acknowledged pioneer in the field of stem cell therapeutics for human heart disease, currently seeing and evaluating patients from all over the world for this new experimental therapy.  Dr. Hare has published multiple clinical trials testing the use of mesenchymal stem cells in patients with heart or age related disorders and is the Principal Investigator of two major NHLBI programs that advance cell based therapy.  He has published over 300 publications and reviews in the peer reviewed literature, holds numerous investigational new drug authorizations (INDs) from the FDA for cell therapy, and has been awarded several U.S. patents.

Sessions
Testimonials
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
    EUFETS GmbH
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
    Dendreon
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman
    GSK